AgomAb Therapeutics NV
Open
$10.65
Prev. Close
$10.71
High
$10.65
Low
$10.64
Market Snapshot
$361.14M
62
Agomab Therapeutics NV is a BE-based company operating in Pharmaceuticals industry. The company employs 62 full-time employees The company went IPO on 2026-02-06. Agomab Therapeutics NV is a Belgium-based company. The firm is engaged in research and development services creating therapies for fibrotic and inflammatory diseases. Its activities include discovery research to identify drug candidates that act on pathways involved in fibrosis and tissue repair, such as organ restricted small molecules and growth factor targeting antibodies. The firm also carries out preclinical development, including work on programs, to evaluate drug behavior and readiness before entering human studies. In addition, It conducts clinical development services by sponsoring and managing trials for its pipeline, assessing safety, tolerability, pharmacokinetics, and pharmacodynamics.
emptyResult
Agomab Therapeutics NV is a BE-based company operating in Pharmaceuticals industry. The company employs 62 full-time employees The company went IPO on 2026-02-06. Agomab Therapeutics NV is a Belgium-based company. The firm is engaged in research and development services creating therapies for fibrotic and inflammatory diseases. Its activities include discovery research to identify drug candidates that act on pathways involved in fibrosis and tissue repair, such as organ restricted small molecules and growth factor targeting antibodies. The firm also carries out preclinical development, including work on programs, to evaluate drug behavior and readiness before entering human studies. In addition, It conducts clinical development services by sponsoring and managing trials for its pipeline, assessing safety, tolerability, pharmacokinetics, and pharmacodynamics.
Recently from Cashu
Couldn't load Cashu news
Something went wrong. Try refreshing the page.